4 participants
A Study to Evaluate the Safety and Tolerability of Venetoclax Tablets in Combination With Capecitabine Tablets in Adult Participants With Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer Who Had Disease Progression During or After CDK4/6 Inhibitor Therapy
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-10-29
- Start Date:
- 2020-05-21
- Completion:
- 2020-10-08
Conditions
- Breast Cancer
- Cancer
Interventions
- DRUG
No Results Yet